Cargando…
Intravenous Immunoglobulin for Autoimmune Bullous Diseases: A Case Series from a Central European Referral Center
Background and Objectives: Autoimmune bullous diseases (AIBDs) may be treated with intravenous immunoglobulin (IVIG) infusions. This study aimed to evaluate the benefits and safety profiles of high-dose IVIG therapy in AIBD patients, as determined by clinical remission, the glucocorticosteroid-spari...
Autores principales: | Spałek, Maciej Marek, Bowszyc-Dmochowska, Monika, Dmochowski, Marian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385677/ https://www.ncbi.nlm.nih.gov/pubmed/37512078 http://dx.doi.org/10.3390/medicina59071265 |
Ejemplares similares
-
Involvement of palms and soles in patients with autoimmune bullous diseases: a comparative analysis of a diagnostically relevant localization
por: Jałowska, Magdalena, et al.
Publicado: (2023) -
Bullous pemphigoid and neurodegenerative diseases: a study in a setting of a Central European university dermatology department
por: Pietkiewicz, Paweł, et al.
Publicado: (2015) -
Case Report: Infantile Bullous Pemphigoid: Triggering by COVID-19 Is Speculative
por: Rosińska-Więckowicz, Anna, et al.
Publicado: (2021) -
Analysis of the autoimmune response against BP180 and BP230 in ethnic Poles with neurodegenerative disorders and bullous pemphigoid
por: Gornowicz-Porowska, Justyna, et al.
Publicado: (2017) -
Neurodegenerative disorders, bullous pemphigoid and psoriasis: a comparative study in ethnic Poles indicates that Parkinson’s disease is more relevant to bullous pemphigoid
por: Bartkiewicz, Paweł, et al.
Publicado: (2017)